ANDA 75358, held by Bausch Health. Albuterol Sulfate.
As of Nov 20, 2026, ANDA 75358 (Albuterol Sulfate), held by Bausch Health, was first approved by FDA on Mar 29, 2000, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 29, 2000 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 0.083% BASE · solution;inhalation | Albuterol Sulfate | Discontinued |
| Sep 21, 2004 | Supplement 14Labeling | Approved | None posted |
| May 14, 2004 | Supplement 12Labeling | Approved | None posted |
| Jul 23, 2002 | Supplement 6Manufacturing | Approved | None posted |
| Nov 27, 2001 | Supplement 5Manufacturing | Approved | None posted |
| Sep 21, 2001 | Supplement 4Manufacturing | Approved | None posted |
| Jan 22, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Jan 22, 2001 | Supplement 2Manufacturing | Approved | None posted |
| Jan 22, 2001 | Supplement 3Labeling | Approved | None posted |
| Mar 29, 2000 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters